EZH2 and gastric cancer: All the functional assays revealed that EZH2 silencing (Figure S1B) promoted the apoptosis of GC cells (Figure S1D) while inhibiting the cell proliferation (Figure S1C), migration (Figure S1E), EMT (Figure S1F) and stemness (Figure S1G).